Drug discovery is the process by which potential new medicines are identified, repurposed and/or designed. This involves a wide [...]
About Griffin FerraraThis author has not yet filled in any details.
So far Griffin Ferrara has created 25 blog entries.
Highlights 3D liver fibrosis models typically incorporate both hepatocytes and various non-parenchymal (NPC) populations. Stimulation of these models [...]
Hampton, NJ – March 9th, 2021 – Visikol today announced its partnership with Bruker to use Bruker’s flagship MuVi [...]
Visikol was originally founded as a products oriented company when it launched its Visikol® HISTO™ portfolio of reagents and [...]
Pharma Tech Outlook acknowledges Visikol and how the company is leveraging its advanced imaging and 3D cell culture solutions [...]
After completing the imaging process for your desired biological model, you may find that some of your images have [...]
Visikol CEO Dr. Michael Johnson will be hosting a webinar with Leica Biosystems discussing multiplex imaging and the Leica [...]
Visikol has been a leader in advanced bioimaging through its portfolio of cutting-edge technologies and innovative drug discovery, bioimaging, [...]
Accurate prediction and prognosis as well as patient stratification for precision therapy are the most important and difficult issues [...]